Cognetivity Neurosciences Ltd.
CGN
CNSX
| 10/31/2023 | 07/31/2023 | 04/30/2023 | 01/31/2023 | 10/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 21.50K | 15.20K | 3.10K | 33.70K | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.50K | 15.20K | 3.10K | 33.70K | -- |
| Cost of Revenue | 353.70K | 284.30K | 413.30K | -40.70K | 548.30K |
| Gross Profit | -332.20K | -269.10K | -410.20K | 74.40K | -548.30K |
| SG&A Expenses | 282.20K | 316.90K | 295.50K | 1.30M | 296.50K |
| Depreciation & Amortization | 5.10K | 5.70K | 5.10K | 3.60K | 4.90K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 672.70K | 669.80K | 833.40K | 1.05M | 1.33M |
| Operating Income | -651.30K | -654.60K | -830.30K | -1.02M | -1.33M |
| Income Before Tax | -1.50M | -1.45M | -1.56M | -1.90M | -1.35M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.50M | -1.45M | -1.56M | -1.90M | -1.35M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.50M | -1.45M | -1.56M | -1.90M | -1.35M |
| EBIT | -651.30K | -654.60K | -830.30K | -1.02M | -1.33M |
| EBITDA | -646.10K | -648.90K | -825.30K | -1.02M | -1.32M |
| EPS Basic | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 88.37M | 87.08M | 85.66M | 85.05M | 79.40M |
| Average Diluted Shares Outstanding | 88.37M | 87.08M | 85.66M | 85.05M | 79.40M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
